EUVIMEDEUVIMED entdecken
Crossref

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma (ALCL) with Worse Outcome: Presentation with Extensive Limb Disease (ELD)

The Internet Journal of Dermatology · 2009

DOI: 10.5580/10ed ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Internet Journal of Dermatology, 2009.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Youn H. Kim, M.D. is the Joanne and Peter Haas Jr. Professor for Cutaneous Lymphoma Research in the Department of Dermatology at Stanford University School of Medicine. She is a member of the Stanford Cancer Center and Director of the Multidisciplinary Cutaneous Lymphoma Clinic and Program at Stanford. She is a member of the NonHodgkin’s Lymphoma Panel of the National Comprehensive Cancer Network and serves on the Advisory Board of the international Society for Cutaneous Lymphomas, the Board of Directors of the US Consortium for Cutaneous Lymphomas, and the Board of Directors of the Medical Dermatology Society. She is an elected member of the American Dermatologic Association, member of the American Society of Hematology, the American Academy of Dermatology, and the Society for Investigative Dermatology.

Zitieren

APA

(2009). Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma (ALCL) with Worse Outcome: Presentation with Extensive Limb Disease (ELD). The Internet Journal of Dermatology. https://doi.org/10.5580/10ed

Vancouver

Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma (ALCL) with Worse Outcome: Presentation with Extensive Limb Disease (ELD). The Internet Journal of Dermatology. 2009. doi:10.5580/10ed

BibTeX
@article{euvimed2009,
  title = {Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma (ALCL) with Worse Outcome: Presentation with Extensive Limb Disease (ELD)},
  journal = {The Internet Journal of Dermatology},
  year = {2009},
  doi = {10.5580/10ed}
}
Kostenlos starten →